A detailed history of British Columbia Investment Management Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 18,083 shares of REGN stock, worth $12.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
18,083
Previous 20,674 12.53%
Holding current value
$12.7 Million
Previous $21.7 Million 12.51%
% of portfolio
0.12%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $2.65 Million - $3.11 Million
-2,591 Reduced 12.53%
18,083 $19 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $6.92 Million - $8.4 Million
7,840 Added 61.09%
20,674 $21.7 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $492,868 - $542,369
546 Added 4.44%
12,834 $12.4 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $1.92 Million - $2.18 Million
2,478 Added 25.26%
12,288 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $79,631 - $97,102
115 Added 1.19%
9,810 $8.07 Million
Q2 2023

Aug 11, 2023

BUY
$700.03 - $830.35 $98,004 - $116,249
140 Added 1.47%
9,695 $6.97 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $31,983 - $38,867
47 Added 0.49%
9,555 $7.85 Million
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $832,950 - $904,340
-1,180 Reduced 11.04%
9,508 $6.86 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $970,009 - $1.22 Million
-1,690 Reduced 13.65%
10,688 $7.36 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $2.16 Million - $2.91 Million
-3,943 Reduced 24.16%
12,378 $7.32 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $1.28 Million - $1.5 Million
-2,147 Reduced 11.63%
16,321 $11.4 Million
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $487,501 - $601,860
-897 Reduced 4.63%
18,468 $11.7 Million
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $71,179 - $84,439
-124 Reduced 0.64%
19,365 $11.7 Million
Q2 2021

Aug 09, 2021

BUY
$472.8 - $558.54 $1.08 Million - $1.27 Million
2,280 Added 13.25%
19,489 $10.9 Million
Q1 2021

Apr 30, 2021

SELL
$446.73 - $548.2 $215,770 - $264,780
-483 Reduced 2.73%
17,209 $8.14 Million
Q4 2020

Feb 02, 2021

BUY
$478.3 - $607.98 $94,703 - $120,380
198 Added 1.13%
17,692 $8.55 Million
Q3 2020

Nov 10, 2020

BUY
$544.75 - $658.21 $725,062 - $876,077
1,331 Added 8.23%
17,494 $9.79 Million
Q2 2020

Aug 12, 2020

BUY
$493.32 - $643.92 $3.6 Million - $4.71 Million
7,307 Added 82.51%
16,163 $10.1 Million
Q1 2020

May 13, 2020

SELL
$336.18 - $494.43 $3.44 Million - $5.07 Million
-10,245 Reduced 53.64%
8,856 $4.32 Million
Q4 2019

Feb 12, 2020

BUY
$274.13 - $376.51 $2.19 Million - $3 Million
7,977 Added 71.71%
19,101 $7.17 Million
Q3 2019

Nov 14, 2019

SELL
$273.46 - $318.39 $4.15 Million - $4.83 Million
-15,168 Reduced 57.69%
11,124 $3.09 Million
Q2 2019

Aug 12, 2019

SELL
$299.6 - $414.82 $2.49 Million - $3.45 Million
-8,307 Reduced 24.01%
26,292 $8.23 Million
Q1 2019

May 08, 2019

SELL
$372.08 - $439.57 $197,946 - $233,851
-532 Reduced 1.51%
34,599 $14.2 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $651,490 - $781,897
1,940 Added 5.84%
35,131 $13.1 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $3.21 Million - $3.73 Million
-9,139 Reduced 21.59%
33,191 $13.4 Million
Q2 2018

Aug 09, 2018

SELL
$284.6 - $344.99 $6.63 Million - $8.04 Million
-23,295 Reduced 35.5%
42,330 $14.6 Million
Q1 2018

May 15, 2018

SELL
$315.82 - $393.78 $74,849 - $93,325
-237 Reduced 0.36%
65,625 $22.6 Million
Q4 2017

Feb 20, 2018

BUY
$358.63 - $469.95 $3.28 Million - $4.3 Million
9,157 Added 16.15%
65,862 $24.8 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $24.5 Million - $28.6 Million
56,705
56,705 $25.4 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.